Other News To Note
Monday, September 12, 2011
Valeant Pharmaceuticals International Inc., of Mississauga, Ontario, said it mailed its offer and takeover bid to shareholders of Afexa Life Sciences Inc., of Edmonton, Alberta. Last month, Valeant made the offer to acquire Afexa for C71 cents (US73 cents) per share, or C$76 million, which trumped an earlier bid by Montreal-based Paladin Labs Inc. Valeant's offer expires at 5 p.m. (Edmonton time) Oct. 17, 2011.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.